What is EMD Serono known for?

With a history of vibrant science and technology, our curiosity fueled the discovery of treatments for multiple sclerosis, infertility and cancer. That curiosity stems from our global company’s DNA, which started more than 350 years ago and makes us part of the world’s oldest pharmaceutical and chemical company.

Does Merck own Serono?

As of January 5, 2007, Merck held the majority shares of Serono. The new company is called Merck Serono international SA.

Who bought Serono?

Merck
Three months after losing a bidding war with Bayer over Schering, Germany’s Merck has announced a deal to buy Switzerland’s Serono, Europe’s biggest biotech drug company, for $13.3 billion.

Does Merck own EMD Serono?

EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada.

What drugs does EMD Serono make?

Drugs

  • BAVENCIO. Bladder, kidney, and other urologic cancers. Melanoma and other skin cancers.
  • CETROTIDE. Infertility.
  • GONAL-F. Infertility.
  • GONAL-F RFF. Infertility.
  • GONAL-F RFF PEN. Infertility.
  • GONAL-F RFF REDI-JECT. Infertility.
  • MAVENCLAD. Multiple sclerosis.
  • OVIDREL. Infertility.

What is the difference between Merck and Merck Serono?

In the United States and Canada, Merck uses its firm name “Merck KGaA, Darmstadt, Germany,” and its businesses operate under “EMD Serono” in Healthcare, “MilliporeSigma” in Life Science and “EMD Electronics” in Electronics.

Is Serrano a biotech company?

Serono was a biotechnology company headquartered in Geneva, Switzerland. It was acquired by the German pharmaceutical company Merck in 2006.

What makes Merck different?

Merck Pharmaceuticals Merck has more than 50 pharmaceutical products to its name. The company specializes in products for cardiovascular, respiratory and infectious diseases. It also focuses on cancer, nervous-system disorders, immunology and women’s health.

Where is Sorono?

Geneva, Switzerland
Serono was a biotechnology company headquartered in Geneva, Switzerland. It was acquired by the German pharmaceutical company Merck in 2006.